权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Midlife Health in Japan (MIDJA) and the U.S. (MIDUS)

日本 (MIDJA) 和美国 (MIDUS) 的中年健康

基本信息

批准号：
8466022
负责人：
CAROL D. RYFF
金额：
$ 0.5万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-04-01 至 2017-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8466022
关键词：
Accounting Adult Affect Age Aging Alleles American Anxiety Area Attenuated Biological Biological Factors Biological Markers Biology Buffers Characteristics Chronic Clinic DNA Data Data Collection Data Set Diagnosis Disadvantaged Economic Recession Economics Educational Status Family Gender Genes Genetic Markers Genetic Polymorphism Goals Health Health behavior Income Inflammation Inflammatory Interleukin-6 Japan Japanese Population Life Life Cycle Stages Link Literature Longitudinal Surveys Mails Major Depressive Disorder Marital Status Measures Mediating Mental Depression Mental Health Methaqualone Modeling Molecular Genetics Mood Disorders Neurosecretory Systems Opioid Outcome Oxytocin Receptor Participant Pathway interactions Patient Self-Report Personal Satisfaction Personality Traits Population Prevalence Probability Samples Process Psychosocial Factor Questionnaires Receptor Gene Regulation Reporting Resources Respondent Risk Saliva Sampling Serotonin Single Nucleotide Polymorphism Social Responsibility Social support Socialization Socioeconomic Status Surveys Symptoms System Testing Time Tokyo age difference age effect aged allostatic load base cardiovascular risk factor comparative cultural values design follow-up immune function low socioeconomic status metropolitan middle age novel physical conditioning psychologic psychosocial resilience satisfaction social social equality socioeconomics

项目摘要

We propose to conduct a survey with a probability sample of Japanese adults (N = 1,000, divided equally by gender) aged 30 to 70 from the Tokyo metropolitan area. Data will be collected on sociodemographic characteristics (age, gender, marital status, educational status, income), psychosocial characteristics (e.g., independence/interdependence, personality traits, sense of control, goal orientations, social support, family obligation, social responsibility), mental health (depression, anxiety, well-being, life satisfaction), and physical health (chronic conditions, health symptoms, functional limitations, health behaviors). These measures parallel those in a national longitudinal sample of midlife Americans known as MIDUS. The central objective is to compare the Japanese sample (MIDJA) with the U.S. sample (MIDUS) to test the hypothesis that the construct of interdependence predicts well-being and health in Japan, whereas the construct of independence predicts well-being and health in the U.S. We also predict age differences in health and well-being, some suggesting cultural similarities (e.g., declining purpose in life with age) and others indicating cultural differences (e.g., more age increments on other aspects of well-being in Japan compared to the U.S.). We also propose to collect biomarkers on approximately half of the Japanese survey sample (n = 500). We will include assessments of neuroendocrine regulation, immune function, and cardiovascular risk. These will parallel biological assessments in Project 4 of the ongoing MIDUS II P01. Thus, in both cultures we will examine linkages between psychosocial factors and biology to test the hypothesis that the construct of interdependence is more strongly linked with biological risk in Japan, whereas the construct of independence is more strongly linked with biological risk in the U.S. A final integrative goal is to combine sociodemographic, psychosocial, and reported health assessments to identify (via recursive partitioning) culture-specific pathways to high or low allostatic load (a multi-system indicator of biological risk). Since our prior submission, we have added extensive findings to Preliminary Studies that demonstrate (with pilot data) support for our guiding hypotheses and also document the feasibility of our proposed biological data collection.

我们建议以日本成年人的概率样本(N = 1000，除以